CYTOKINETICS, INCORPORATED (CYTK) Operating cash flow 2016–2025
CYTOKINETICS, INCORPORATED (CYTK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$510.0MFY2025 · since FY2016: $37.0M → -$510.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$510.0M | -28.8% |
| FY2024 | -$395.9M | +4.5% |
| FY2023 | -$414.3M | -38.3% |
| FY2022 | -$299.5M | -110.2% |
| FY2021 | -$142.5M | -1693.7% |
| FY2020 | $8.9M | +109.8% |
| FY2019 | -$90.9M | +10.2% |
| FY2018 | -$101.2M | +0.5% |
| FY2017 | -$101.8M | -375.2% |
| FY2016 | $37.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTK financial trends
CYTK RevenueCYTK Net incomeCYTK Net marginCYTK Gross profitCYTK Gross marginCYTK Operating incomeCYTK Operating marginCYTK Free cash flowCYTK Capital expendituresCYTK Return on equityCYTK Stock buybacksCYTK Dividends paidCYTK Total assetsCYTK Total liabilitiesCYTK Shareholders’ equityCYTK overview →